AMAG Pharmaceuticals
AMAG
AMAG was delisted on the 13th of November, 2020.
172 hedge funds and large institutions have $1.32B invested in AMAG Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 66 increasing their positions, 54 reducing their positions, and 74 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 54
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4.06% less ownership
Funds ownership: 131.25% → 127.19% (-4.1%)
18% less funds holding
Funds holding: 210 → 172 (-38)
26% less capital invested
Capital invested by funds: $1.78B → $1.32B (-$468M)
49% less call options, than puts
Call options by funds: $1.36M | Put options by funds: $2.66M
51% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 74
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$27.1M |
| 2 |
D.E. Shaw & Co
New York
|
+$25M |
| 3 |
State Street
Boston,
Massachusetts
|
+$24.2M |
| 4 |
SIM
Stelliam Investment Management
New York
|
+$22.1M |
| 5 |
Millennium Management
New York
|
+$22.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$39.9M |
| 2 |
CI
Cambiar Investors
Denver,
Colorado
|
-$27.7M |
| 3 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$25.4M |
| 4 |
GAM
Gotham Asset Management
New York
|
-$25.2M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$23.2M |
AMAG Hedge Fund Activity: Q4 2015 in Review
172 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q4 2015, worth a combined $1.32B — down 26% from $1.78B a quarter earlier.
Sellers outnumbered buyers: 74 funds closed out of AMAG and 36 opened new positions — a net loss of 38 holders — while 54 trimmed existing stakes and 66 added.
The largest buyer was Janus Henderson Investors US, adding an estimated $27.1M. The largest seller was Wells Fargo, cutting an estimated $39.9M.
- 172 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q4 2015, down from 210 in Q3 2015.
- Funds reported $1.32B of AMAG Pharmaceuticals stock for Q4 2015, down 26% quarter-over-quarter.
- 36 funds opened new AMAG Pharmaceuticals positions in Q4 2015 and 74 closed out, a net change of -38 holders.
- The largest AMAG Pharmaceuticals buyer in Q4 2015 was Janus Henderson Investors US, an estimated $27.1M added.
- The largest AMAG Pharmaceuticals seller in Q4 2015 was Wells Fargo, an estimated $39.9M sold.
Based on aggregated 13F filings for Q4 2015.